LAM lung destruction results from the presence of abnormal LAM cells, which have both melanocyte and smooth muscle cell characteristics and harbor mutations of the TSC1 or TSC2 genes [5–7]. The gene discussed is TSC1; the disease is lymphangioleiomyomatosis.